KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TAK) Debt Ratio (2018 - 2026)

Takeda Pharmaceutical has reported Debt Ratio over the past 9 years, most recently at 0.28 for Q1 2026.

  • For Q1 2026, Debt Ratio fell 49.21% year-over-year to 0.28; the TTM value through Mar 2026 reached 0.28, down 49.21%, while the annual FY2026 figure was 0.28, 49.21% down from the prior year.
  • Debt Ratio was 0.28 for Q1 2026 at Takeda Pharmaceutical, down from 0.56 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.56 in Q1 2025 and bottomed at 0.05 in Q1 2022.
  • The 5-year median for Debt Ratio is 0.28 (2026), against an average of 0.25.
  • Year-over-year, Debt Ratio crashed 82.48% in 2024 and then skyrocketed 911.93% in 2025.
  • Over 5 years, Debt Ratio stood at 0.05 in 2022, then surged by 522.17% to 0.31 in 2023, then plummeted by 82.48% to 0.06 in 2024, then skyrocketed by 911.93% to 0.56 in 2025, then plummeted by 49.21% to 0.28 in 2026.
  • The last three reported values for Debt Ratio were 0.28 (Q1 2026), 0.56 (Q1 2025), and 0.06 (Q1 2024) per Business Quant data.